ELK4 and neoplasm: Markedly increased tumor burdens in the lungs and liver were validated by hematoxylin and eosin (H&E) staining in mice injected with ELK4‐overexpressing cells, suggesting that overexpression of ELK4 enhances tumor metastasis in CRC (Figure 1D).